Vanguard Group Inc. Grows Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)
Vanguard Group Inc. raised its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 1.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,774,884 shares of the biotechnology company’s stock after buying an additional 91,450 shares during the period. […]
Vanguard Group Inc. raised its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 1.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,774,884 shares of the biotechnology company’s stock after buying an additional 91,450 shares during the period. […]
-logo-1200x675.jpg?v=20210326142732&w=240&h=240&zc=2){kind=logo}
